Bryan A Sisk1, Tammy I Kang2,3, Jennifer W Mack4,5. 1. Division of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, 4523 Clayton Avenue, Campus Box 8005, St. Louis, MO, 63110, USA. siskb@wustl.edu. 2. Section of Pediatric Palliative Care, Texas Children's Hospital, Houston, TX, USA. 3. Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. 4. Pediatric Oncology and Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. 5. Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.
Abstract
PURPOSE: Parents of children with cancer make treatment decisions in highly emotional states while feeling overwhelmed with information. In previous work, 1 in 6 parents demonstrated heightened decisional regret regarding treatment at diagnosis. However, it is unclear how regret evolves over time. We aimed to determine whether parents of children with cancer experience decisional regret over time and to identify parental characteristics and clinician behaviors associated with longitudinal regret. METHODS: Prospective, questionnaire-based cohort study of parents of children with cancer at two academic pediatric hospitals. Parents reported decisional regret at diagnosis, 4 months, and 12 months. RESULTS: At baseline, 13% of parents (21/158) reported heightened regret, 11% (17/158) at 4 months (p = 0.43, McNemar's test relative to baseline), and 11% (16/158) at 12 months (p = 0.35 relative to baseline and p = 0.84 relative to 4 months). In multivariable analysis using generalized estimating equations adjusted for the time point of survey completion, heightened regret was associated with non-white race/ethnicity (OR 11.57, 95% CI 3.53 to 41.05, p < .0001) and high anxiety (OR 2.01, 95% CI 1.04 to 3.90, p = .04). Parents with high peace of mind (OR 0.24, 95% CI 0.09 to 0.62, p = .003) and those reporting high-quality information (OR 0.22, 95% CI 0.07 to 0.69, p = 0.01) had lower odds of heightened regret. We found no association between heightened regret and the time point of survey administration. CONCLUSIONS: A small, significant proportion of parents experience heightened regret throughout the first year of their child's cancer treatment; non-white parents are at higher risk. Effective communication may protect against regret.
PURPOSE: Parents of children with cancer make treatment decisions in highly emotional states while feeling overwhelmed with information. In previous work, 1 in 6 parents demonstrated heightened decisional regret regarding treatment at diagnosis. However, it is unclear how regret evolves over time. We aimed to determine whether parents of children with cancer experience decisional regret over time and to identify parental characteristics and clinician behaviors associated with longitudinal regret. METHODS: Prospective, questionnaire-based cohort study of parents of children with cancer at two academic pediatric hospitals. Parents reported decisional regret at diagnosis, 4 months, and 12 months. RESULTS: At baseline, 13% of parents (21/158) reported heightened regret, 11% (17/158) at 4 months (p = 0.43, McNemar's test relative to baseline), and 11% (16/158) at 12 months (p = 0.35 relative to baseline and p = 0.84 relative to 4 months). In multivariable analysis using generalized estimating equations adjusted for the time point of survey completion, heightened regret was associated with non-white race/ethnicity (OR 11.57, 95% CI 3.53 to 41.05, p < .0001) and high anxiety (OR 2.01, 95% CI 1.04 to 3.90, p = .04). Parents with high peace of mind (OR 0.24, 95% CI 0.09 to 0.62, p = .003) and those reporting high-quality information (OR 0.22, 95% CI 0.07 to 0.69, p = 0.01) had lower odds of heightened regret. We found no association between heightened regret and the time point of survey administration. CONCLUSIONS: A small, significant proportion of parents experience heightened regret throughout the first year of their child's cancer treatment; non-white parents are at higher risk. Effective communication may protect against regret.
Authors: Armando J Lorenzo; João L Pippi Salle; Bozana Zlateska; Martin A Koyle; Darius J Bägli; Luis H P Braga Journal: J Urol Date: 2014-03-26 Impact factor: 7.450
Authors: Jennifer L Malin; Clifford Ko; John Z Ayanian; David Harrington; David R Nerenz; Katherine L Kahn; Julie Ganther-Urmie; Paul J Catalano; Alan M Zaslavsky; Robert B Wallace; Edward Guadagnoli; Neeraj K Arora; Maryse D Roudier; Patricia A Ganz Journal: Support Care Cancer Date: 2006-02-16 Impact factor: 3.603
Authors: Jennifer W Mack; E Francis Cook; Joanne Wolfe; Holcombe E Grier; Paul D Cleary; Jane C Weeks Journal: J Clin Oncol Date: 2007-04-10 Impact factor: 44.544
Authors: Rachel S Fisher; Hannah C Espeleta; Laurence S Baskin; Cindy L Buchanan; Yee-Ming Chan; Earl Y Cheng; Douglas E Coplen; David A Diamond; Natalie J Nokoff; Blake W Palmer; Dix P Poppas; Kristy J Scott Reyes; Amy Tishelman; Cortney Wolfe-Christensen; Larry L Mullins; Amy B Wisniewski Journal: J Pediatr Urol Date: 2021-10-25 Impact factor: 1.830
Authors: Bryan A Sisk; Kieandra Harvey; Annie B Friedrich; Alison L Antes; Lauren H Yaeger; Jennifer W Mack; James M DuBois Journal: Pediatr Blood Cancer Date: 2021-10-18 Impact factor: 3.167
Authors: Bryan A Sisk; Megan Keenan; Melody S Goodman; Argentina E Servin; Lauren H Yaeger; Jennifer W Mack; James M DuBois Journal: Patient Educ Couns Date: 2021-12-30
Authors: Bryan A Sisk; Megan A Keenan; Lindsay J Blazin; Erica Kaye; Justin N Baker; Jennifer W Mack; James M DuBois Journal: Pediatr Blood Cancer Date: 2021-04-16 Impact factor: 3.838
Authors: Bryan A Sisk; Annie B Friedrich; Erica C Kaye; Justin N Baker; Jennifer W Mack; James M DuBois Journal: Cancer Date: 2021-02-17 Impact factor: 6.921
Authors: Dylan E Graetz; Silvia Rivas; Huiqi Wang; Yuvanesh Vedaraju; Gia Ferrara; Lucia Fuentes; Ana Cáceres-Serrano; Federico Antillon-Klussmann; Meenakshi Devidas; Monika Metzger; Carlos Rodriguez-Galindo; Jennifer W Mack Journal: BMJ Open Date: 2022-08-11 Impact factor: 3.006